Marco Vivarelli, Giuliano La Barba, Cristina Legnani, Alessandro Cucchetti, Roberto Bellusci, Gualtiero Palareti, Antonino Cavallari – 30 December 2003 – Hepatic artery thrombosis (HAT) is a main cause of graft loss and patient mortality after orthotopic liver transplantation (OLT). Several surgical and nonsurgical risk factors have been associated with HAT. Retransplantation often is the only possible treatment for this complication; however, the incidence of recurrence of HAT after retransplantation and the underlying conditions of this occurrence have never been investigated.

Juliet Compston – 30 December 2003

Garrett M. Hisatake, Teng‐Wei Chen, John F. Renz, Douglas G. Farmer, R. Mark Ghobrial, Hasan Yersiz, Rafael G. Amado, Leonard Goldstein, Ronald W. Busuttil – 30 December 2003 – It is well recognized that orthotopic liver transplantation rapidly corrects the coagulation disorder observed in patients with hemophilia A or B combined with end‐stage liver disease; however, the transmission of hemophilia from a donor to a transplant recipient has not been reported previously.

Janis E. Blair, Vijayan Balan, David D. Douglas, Joseph G. Hentz – 30 December 2003 – Coccidioidomycosis is an endemic fungal infection of the desert southwestern United States. Patients with end‐stage liver disease (ESLD) have not been described as having a high rate of coccidioidal infection. We prospectively evaluated 290 patients with ESLD for liver transplantation and found that 6 of these patients )2.1%) had active coccidioidal infection at presentation.

Wendy J. Grant, Timothy McCashland, Jean F. Botha, Byers W. Shaw, Debra L. Sudan, Alejandro Mejia, Kishore Iyer, Alan N. Langnas – 30 December 2003 – A 26‐year‐old woman presented with acute Budd‐Chiari syndrome 18 weeks into a pregnancy. She was found to be heterozygous for the G20210A prothrombin gene mutation. She was treated with portacaval shunt placement and successfully completed the pregnancy, with a healthy baby delivered at 31 weeks' gestation.

Robert J. Fontana, Robert M. Merion – 30 December 2003

Antonino Cavallari, Umberto Cillo, Bruno Nardo, Franco Filipponi, Enrico Gringeri, Roberto Montalti, Fabio Vistoli, Francesco D'Amico, Antonio Faenza, Franco Mosca, Alessandro Vitale, Davide D'Amico – 30 December 2003 – Primary dysfunction (PDF) still occurs after orthotopic liver transplantation (OLT). Celsior solution (CS) might offer some advantages over the conventional University of Wisconsin (UW) solution for organ preservation, but to date, this has not been prospectively evaluated in the context of OLT.

Cengizhan Yigitler, Olivier Farges, Reza Kianmanesh, Jean‐Marc Regimbeau, Eddie K. Abdalla, Jacques Belghiti – 30 December 2003 – The maximum extent of hepatic resection compatible with a safe postoperative outcome is unknown. The study goal was to determine the incidence and impact of a small remnant liver volume after major liver resection in patients with normal liver parenchyma.

Koenraad J. Mortelé, Vito Cantisani, Roberto Troisi, Bernard de Hemptinne, Stuart G. Silverman – 30 December 2003 – This article discusses the rationale behind living (related) donor liver transplantation, the role of imaging in the preoperative evaluation of the potential donor, and the currently available imaging modalities for fulfilling this task. Furthermore, the normal hepatic vascular and biliary anatomy, as seen on imaging, is reviewed and the most common anomalies are highlighted.

Sammy Saab, Albert J. Chang, Scott Comulada, Sunil K. Geevarghese, R. Dean M. Anselmo, Francisco Durazo, Steven Han, Douglas G. Farmer, Hasan Yersiz, Leonard I. Goldstein, R. Mark Ghobrial, Ronald W. Busuttil – 30 December 2003 – The use of hepatitis B core antibody (HBcAb)‐ and hepatitis C virus antibody (HCV+) liver grafts for transplantation in selected populations has not affected patient and graft survival. We reexamined the clinical outcomes of using these HBcAb+ and HCV+ grafts at our institution, in addition to studying recipients of combined HBcAb+/HCV+ grafts.